Fig. 1.
Changes in cytotoxicity of PBMCs for autologous PHA blasts after ASCT.
The cytotoxicity for autologous PHA blasts obtained at different time points after ASCT was determined using the standard 51Cr release assay with an effector–target ratio of 80. ■, patient 1; ▵, patient 2; ○, patient 3; ⋄, patient 4; ▪, patient 6; ▴, patient 7; ●, patient 8; ♦, a patient not administered CsA and IFN-γ.
